223 related articles for article (PubMed ID: 33079366)
21. Streptococcal toxic shock syndrome from necrotizing soft-tissue infection of the breast caused by a mucoid type strain.
Kohayagawa Y; Ishitobi N; Yamamori Y; Wakuri M; Sano C; Tominaga K; Ikebe T
J Infect Chemother; 2015 Feb; 21(2):144-7. PubMed ID: 25260866
[TBL] [Abstract][Full Text] [Related]
22. Case 28-2002: a traveler with a rapidly progressive soft-tissue infection.
Johnson JR; Gandhi R
N Engl J Med; 2003 Jan; 348(2):176-7; author reply 176-7. PubMed ID: 12519934
[No Abstract] [Full Text] [Related]
23. Risk Factors and Predictors of Mortality in Streptococcal Necrotizing Soft-tissue Infections: A Multicenter Prospective Study.
Bruun T; Rath E; Madsen MB; Oppegaard O; Nekludov M; Arnell P; Karlsson Y; Babbar A; Bergey F; Itzek A; Hyldegaard O; Norrby-Teglund A; Skrede S;
Clin Infect Dis; 2021 Jan; 72(2):293-300. PubMed ID: 31923305
[TBL] [Abstract][Full Text] [Related]
24. Randomized, Controlled Trial of Intravenous Immunoglobulin for Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections.
Williams KA; Swedo SE; Farmer CA; Grantz H; Grant PJ; D'Souza P; Hommer R; Katsovich L; King RA; Leckman JF
J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):860-867.e2. PubMed ID: 27663941
[TBL] [Abstract][Full Text] [Related]
25. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.
Shah SS; Hall M; Srivastava R; Subramony A; Levin JE
Clin Infect Dis; 2009 Nov; 49(9):1369-76. PubMed ID: 19788359
[TBL] [Abstract][Full Text] [Related]
26. Non-Necrotizing Soft Tissue Infection and Streptococcal Toxic Shock Syndrome Caused by a Novel Streptococcus pyogenes Subtype (emm76.10).
Hashiyama T; Mori N; Fukushima Y; Takahashi T
Jpn J Infect Dis; 2020 Sep; 73(5):373-376. PubMed ID: 32350222
[TBL] [Abstract][Full Text] [Related]
27. Diffuse venous thromboemboli associated with IVIg therapy in the treatment of streptococcal toxic shock syndrome: case report and review.
Geller JL; Hackner D
Ann Hematol; 2005 Sep; 84(9):601-4. PubMed ID: 15815906
[TBL] [Abstract][Full Text] [Related]
28. A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes.
Ramachandran G; Tulapurkar ME; Harris KM; Arad G; Shirvan A; Shemesh R; Detolla LJ; Benazzi C; Opal SM; Kaempfer R; Cross AS
J Infect Dis; 2013 Jun; 207(12):1869-77. PubMed ID: 23493729
[TBL] [Abstract][Full Text] [Related]
29. Role of intravenous immune globulin in streptococcal toxic shock syndrome and Clostridium difficile infection.
Shah PJ; Vakil N; Kabakov A
Am J Health Syst Pharm; 2015 Jun; 72(12):1013-9. PubMed ID: 26025992
[TBL] [Abstract][Full Text] [Related]
30. Effects of low-dose intravenous immunoglobulin as the adjunctive therapy in septic shock patients with and without hypogammaglobulinemia: a retrospective cohort study.
Goto K; Yasuda N; Sato Y
Ann Palliat Med; 2022 Aug; 11(8):2600-2608. PubMed ID: 35695053
[TBL] [Abstract][Full Text] [Related]
31. Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome.
Schrage B; Duan G; Yang LP; Fraser JD; Proft T
Clin Infect Dis; 2006 Sep; 43(6):743-6. PubMed ID: 16912949
[TBL] [Abstract][Full Text] [Related]
32. Clinical usefulness of intravenous human immunoglobulins in invasive group A Streptococcal infections: case report and review.
Lamothe F; D'Amico P; Ghosn P; Tremblay C; Braidy J; Patenaude JV
Clin Infect Dis; 1995 Dec; 21(6):1469-70. PubMed ID: 8749635
[TBL] [Abstract][Full Text] [Related]
33. Should Linezolid Replace Clindamycin as the Adjunctive Antimicrobial of Choice in Group A Streptococcal Necrotizing Soft Tissue Infection and Toxic Shock Syndrome? A Focused Debate.
Cortés-Penfield N; Ryder JH
Clin Infect Dis; 2023 Jan; 76(2):346-350. PubMed ID: 36056891
[TBL] [Abstract][Full Text] [Related]
34. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach.
Chapman SJ; Opdam H; Donato R; Johnson PD
Scand J Infect Dis; 2006; 38(8):742-3. PubMed ID: 16857634
[No Abstract] [Full Text] [Related]
35. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
Laupland KB; Kirkpatrick AW; Delaney A
Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
[TBL] [Abstract][Full Text] [Related]
36. Effect of immunoglobulin G on cytokine response in necrotising soft-tissue infection: A post hoc analysis.
Hedetoft M; Madsen MB; Perner A; Garred P; Hyldegaard O
Acta Anaesthesiol Scand; 2021 Oct; 65(9):1293-1299. PubMed ID: 34138468
[TBL] [Abstract][Full Text] [Related]
37. ICU Management of Invasive β-Hemolytic Streptococcal Infections.
Babiker A; Kadri SS
Infect Dis Clin North Am; 2022 Dec; 36(4):861-887. PubMed ID: 36328640
[TBL] [Abstract][Full Text] [Related]
38. Pathogenic Mechanisms of Streptococcal Necrotizing Soft Tissue Infections.
Siemens N; Snäll J; Svensson M; Norrby-Teglund A
Adv Exp Med Biol; 2020; 1294():127-150. PubMed ID: 33079367
[TBL] [Abstract][Full Text] [Related]
39. The importance of intravenous immunoglobulin treatment in critically ill patients with necrotizing soft tissue infection: a retrospective cohort study.
Hofmaenner DA; Wendel Garcia PD; Blum MR; David S; Schuepbach RA; Buehler PK; Frey PM; Zinkernagel AS; Brugger SD
BMC Infect Dis; 2022 Feb; 22(1):168. PubMed ID: 35189821
[TBL] [Abstract][Full Text] [Related]
40. Toxic shock syndrome: major advances in pathogenesis, but not treatment.
Low DE
Crit Care Clin; 2013 Jul; 29(3):651-75. PubMed ID: 23830657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
